Clinical impacts of genomic copy number gains at Xq28
Human Genome Variation · 2014
DOI: 10.1038/hgv.2014.1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Genome Variation, 2014. Verfasst von Toshiyuki Yamamoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan; Department of Pediatrics, Tokyo Women's Medical University,…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Duplications of the Xq28 region are the most frequent chromosomal aberrations observed in patients with intellectual disability (ID), especially in males. These duplications occur by variable mechanisms, including interstitial duplications mediated by segmental duplications in this region and terminal duplications (functional disomy) derived from translocation with other chromosomes. The most commonly duplicated region includes methyl CpG-binding protein 2 gene ( MECP2 ), which has a minimal duplicated size of 0.2 Mb. Patients with MECP2 duplications show severe ID, intractable seizures and recurrent infections. Duplications in the telomeric neighboring regions, which include GDP dissociation inhibitor 1 gene ( GDI1 ) and ras-associated protein RAB39B gene ( RAB39B ), are independently associated with ID, and many segmental duplications located in this region could mediate these frequently observed interstitial duplications. In addition, large duplications, including MECP2 and GDI1 , induce hypoplasia of the corpus callosum. Abnormalities observed in the white matter, revealed by brain magnetic resonance imaging, are a common finding in patients with MECP2 duplications. As primary sequence analysis cannot be used to determine the region responsible for chromosomal duplication syndrome, finding this region relies on the collection of genotype–phenotype data from patients.
Autor:innen und Institutionen
- Tokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan; Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
- Tokyo Women's Medical University Institute for Integrated Medical Sciences , Tokyo, Japan.
- Department of Pediatric Neurology, Mikatahara General Hospital , Hamamatsu, Japan.
- National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders , Shizuoka, Japan.
- Department of Pediatric Neurology, Osaka Medical Center and Research Institute for Maternal and Child Health , Izumi, Japan.
- Department of Medical Genetics, Osaka Medical Center and Research Institute for Maternal and Child Health , Izumi, Japan .
ORCID-Profile: Toshiyuki Yamamoto
Zitieren
APA
Yamamoto, T., Shimojima, K., Shimada, S., Yokochi, K., Yoshitomi, S., Yanagihara, K., Imai, K., & Okamoto, N. (2014). Clinical impacts of genomic copy number gains at Xq28. Human Genome Variation. https://doi.org/10.1038/hgv.2014.1
Vancouver
Yamamoto T, Shimojima K, Shimada S, Yokochi K, Yoshitomi S, Yanagihara K, et al. Clinical impacts of genomic copy number gains at Xq28. Human Genome Variation. 2014. doi:10.1038/hgv.2014.1
BibTeX
@article{Yamamoto2014,
author = {Yamamoto, Toshiyuki and Shimojima, Keiko and Shimada, Shino and Yokochi, Kenji and Yoshitomi, Shinsaku and Yanagihara, Keiko and Imai, Katsumi and Okamoto, Nobuhiko},
title = {Clinical impacts of genomic copy number gains at Xq28},
journal = {Human Genome Variation},
year = {2014},
doi = {10.1038/hgv.2014.1}
}
EUVIMED